Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
PUT
Atlassian
TEAM
$48.2B
| $1.71M | ﹤0.01% |
57,000
+31,000
| +119% | +$907K |
|
|
ANAT
3802
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.71M | ﹤0.01% |
14,006
-6,007
| -30% | -$693K |
|
|
WNRL
3803
PUT
DELISTED
Western Refining Logistics, LP
WNRL
| $1.71M | ﹤0.01% |
73,700
+34,000
| +86% | +$806K |
|
3804
Argan
AGX
$5.86B
| $1.71M | ﹤0.01% |
28,837
-7,435
| -20% | -$365K |
|
3805
CALL
LiveRamp
RAMP
$2.29B
| $1.71M | ﹤0.01% |
64,000
+19,300
| +43% | +$477K |
|
3806
CALL
Carlisle Companies
CSL
$14.2B
| $1.7M | ﹤0.01% |
16,600
+14,200
| +592% | +$1.48M |
|
3807
LGI Homes
LGIH
$1.34B
| $1.7M | ﹤0.01% |
46,234
+15,232
| +49% | +$537K |
|
|
TDAY
3808
USA Today Co
TDAY
$931M
| $1.7M | ﹤0.01% |
109,840
+46,092
| +72% | +$793K |
|
3809
CALL
SiriusXM
SIRI
$9.62B
| $1.7M | ﹤0.01% |
40,800
-232,220
| -85% | -$9.69M |
|
3810
CALL
Nice
NICE
$6.38B
| $1.7M | ﹤0.01% |
25,400
-1,200
| -5% | -$79.9K |
|
3811
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$267M
| $1.7M | ﹤0.01% |
48,198
-7,403
| -13% | -$263K |
|
3812
Vanguard Industrials ETF
VIS
$8.07B
| $1.7M | ﹤0.01% |
15,317
-45,249
| -75% | -$5M |
|
|
VGR
3813
CALL
DELISTED
Vector Group Ltd.
VGR
| $1.7M | ﹤0.01% |
128,785
+17,212
| +15% | +$225K |
|
|
ACH
3814
PUT
Accendra Health
ACH
$93.1M
| $1.7M | ﹤0.01% |
48,900
+30,800
| +170% | +$1.08M |
|
3815
ProShares Ultra 20+ Year Treasury
UBT
$58M
| $1.7M | ﹤0.01% |
34,974
+14,526
| +71% | +$715K |
|
3816
CALL
iShares International Treasury Bond ETF
IGOV
$1.54B
| $1.7M | ﹤0.01% |
+33,800
| New | +$1.69M |
|
|
EQC
3817
DELISTED
Equity Commonwealth
EQC
| $1.7M | ﹤0.01% |
56,156
+24,479
| +77% | +$739K |
|
3818
AMN Healthcare
AMN
$1.34B
| $1.7M | ﹤0.01% |
+53,228
| New | +$2.02M |
|
3819
PUT
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
| $1.69M | ﹤0.01% |
15,300
+1,300
| +9% | +$143K |
|
3820
PUT
ProShares Ultra Bloomberg Natural Gas
BOIL
$415M
| $1.69M | ﹤0.01% |
12
+2
| +20% | +$304K |
|
|
SF
3821
CALL
Stifel
SF
$12.3B
| $1.69M | ﹤0.01% |
98,775
-11,925
| -11% | -$192K |
|
3822
PUT
Boise Cascade
BCC
$2.75B
| $1.69M | ﹤0.01% |
66,400
-12,700
| -16% | -$326K |
|
3823
PUT
Sabre
SABR
$888M
| $1.69M | ﹤0.01% |
59,800
-30,400
| -34% | -$849K |
|
3824
CALL
Ollie's Bargain Outlet
OLLI
$4.38B
| $1.68M | ﹤0.01% |
64,200
-24,500
| -28% | -$639K |
|
3825
CALL
Lennox International
LII
$13.6B
| $1.68M | ﹤0.01% |
10,700
-26,900
| -72% | -$4.18M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.